Martinón-Torres, Federico <br/><br/>
Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial.  [electronic resource] 

 -  Vaccine  06 2017 
 - 3548-3557 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2017.05.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bacterial--blood<br/>Antibodies, Blocking--blood<br/>Child<br/>Child, Preschool<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Humans<br/>Immunization Schedule<br/>Immunogenicity, Vaccine<br/>Infant<br/>Male<br/>Meningococcal Infections--immunology<br/>Meningococcal Vaccines--administration & dosage<br/>Neisseria meningitidis--immunology<br/>Neisseria meningitidis, Serogroup B--immunology<br/>Research Design<br/>Serogroup<br/>Vaccination